BiotechTube
Home/FcR Therapeutics/Guido Maertens, MSc
GM

Guido Maertens, MSc

Chief Executive Officer & Chief Financial Officer

FcR Therapeutics

Therapeutic Areas

Autoimmune Diseases

FcR Therapeutics Pipeline

DrugIndicationPhase
Undisclosed FcR-targeting Nanobody Program(s)Autoimmune DiseasesPre-clinical

Leadership Team at FcR Therapeutics

GV
Geert van Tetering, PhD
Chief Operating Officer & Chief Scientific Officer
MD
Mark de Boer, PhD
Senior Vice President Corporate Development
View full FcR Therapeutics profile